Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$14.88 - $32.78 $223,200 - $491,700
-15,000 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$27.65 - $38.39 $414,750 - $575,850
-15,000 Reduced 50.0%
15,000 $477,000
Q1 2018

May 15, 2018

BUY
$29.84 - $44.08 $298,400 - $440,800
10,000 Added 50.0%
30,000 $995,000
Q3 2017

Nov 14, 2017

BUY
$15.81 - $24.01 $316,200 - $480,200
20,000
20,000 $480,000

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $122M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Morgens Waterfall Vintiadis & CO Inc Portfolio

Follow Morgens Waterfall Vintiadis & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgens Waterfall Vintiadis & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Morgens Waterfall Vintiadis & CO Inc with notifications on news.